<DOC>
	<DOCNO>NCT01783964</DOCNO>
	<brief_summary>This study perform measure quantity i.v . apply elacytarabine leave body , route fast .</brief_summary>
	<brief_title>Elacytarabine Mass Balance Study Healthy Volunteers</brief_title>
	<detailed_description>This single centre , open-label , non-randomised single dose study healthy male subject . Each subject receive single 15 min IV administration 14C label elacytarabine . In study , least 6 subject dose order obtain data 4 evaluable subject .</detailed_description>
	<mesh_term>Cytarabine</mesh_term>
	<criteria>1 . Healthy male 2 . Age 50 65 year age 4 . Must willing able communicate participate whole study 5 . Must provide write informed consent 6 . Must agree use adequate method contraception 1 . Participation clinical research study within previous 3 month 2 . Subjects study site employee , immediate family member study site sponsor employee 3 . Subjects previously enrol study elacytarabine study 4 . History drug alcohol abuse past 2 year 7 . Radiation exposure , include present study , exclude background radiation include diagnostic xrays medical exposure , exceed 5 mSv last 12 month 10 mSv last 5 year . No occupationally expose worker , define Ionising Radiation Regulations 1999 , shall participate study 8 . Subjects suitable vein multiple venepunctures IV administration assess investigator screen 9 . Clinically significant abnormal biochemistry , haematology urinalysis judge investigator 10 . Positive drug abuse test result 11 . Positive hepatitis B surface antigen ( HBsAg ) , hepatitis C virus antibody ( HCV Ab ) human immunodeficiency virus ( HIV ) result 12 . History cardiovascular , renal , hepatic , chronic respiratory gastrointestinal disease judge investigator 13 . Serious adverse reaction serious hypersensitivity drug formulation excipients 14 . Presence history allergy require treatment . Hayfever allow unless active 15 . Donation loss great 400 mL blood within previous 3 month 16 . Subjects take , take , prescribed overthecounter drug ( 4 g per day paracetamol ) herbal remedy 14 day IMP administration 17 . Failure satisfy investigator fitness participate reason</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Elacytarabine</keyword>
	<keyword>pharmacokinetic</keyword>
	<keyword>Microdose</keyword>
	<keyword>Mass Balance Recovery</keyword>
</DOC>